Skip to Main Content
Services Talent Knowledge
Site Search
Menu

PressRelease

November 22, 2022

Naomi Levin Joins Barclay Damon

November 22, 2022—Barclay Damon announces Naomi Levin, counsel, has joined Barclay Damon’s Trusts & Estates Practice Area. Her primary office location is New York City.

Levin has extensive experience in a wide range of trusts and estates matters. She represents fiduciaries and interested parties in estate and trust administration, planning, and litigation as well as business succession planning. Levin also represents clients in connection with special needs guardianship proceedings, specifically Article 81 and Article 17-A, and related matters. In addition to her trusts and estates practice, Levin counsels her clients on a variety of initial and post-eligibility Medicaid matters.

Barclay Damon attorneys team across offices and practices to provide customized, targeted solutions grounded in industry knowledge and a deep understanding of our clients’ businesses. With nearly 300 attorneys, Barclay Damon is a leading law firm that operates from a strategic platform of offices located in the Northeastern United States and Toronto. For more information, visit our award-winning website at barclaydamon.com.

Subscribe

Click here to sign up for alerts, blog posts, and firm news.

Featured Media

Alerts

Attention Providers! OMIG Audit Update: New Settlement Flexibility at Lower Confidence Payment Restored and DME Protocol Released

Alerts

NYS Trial Court Holds: Animals Are Family Too

Alerts

Website Accessibility Lawsuits: Several "Tester" Plaintiffs—Victor Lopez, Myrna Driffin, Damon Jones, Tazinique Echols, and Ashley Bahena—Targeting Businesses in Recent Flurry of Lawsuits

Alerts

Website Accessibility Lawsuits: Several "Tester" Plaintiffs—Brian Flores Gerardo, Jonathan Drummond, Makeda Evans, Andre Campbell, and Zephyrin Victor—Targeting Businesses in Recent Flurry of Lawsuits

Alerts

New York State Executive Order Expands Pharmacist Authority to Administer COVID-19 Vaccines Without Prescription

Alerts

Federal Judge Halts DOE's Crackdown on Diversity Programs